Related Experiment Video
Updated: Jun 21, 2026
09:01
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Inflammation and colorectal cancer
1Integrated Cancer Prevention Center, Tel Aviv Souraski Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel.
Current Opinion in Pharmacology
|July 11, 2009
Summary
Patients with inflammatory bowel disease (IBD) face higher colorectal cancer (CRC) risks due to chronic inflammation. Key inflammatory mediators and pathways like COX-2 and NF-kappaB link inflammation to cancer development.
Area of Science:
- Gastroenterology
- Oncology
- Immunology
Background:
- Patients with long-standing inflammatory bowel disease (IBD) exhibit an elevated risk of colorectal cancer (CRC).
- The precise mechanisms underlying this increased CRC risk in IBD patients are not fully understood.
- Genetic factors alone do not entirely account for the heightened cancer susceptibility.
Purpose of the Study:
- To review the pathogenesis of colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD).
- To summarize the molecular mechanisms linking chronic inflammation to the development of intestinal neoplasia in IBD.
- To explore the role of inflammatory mediators and signaling pathways in IBD-associated CRC.
Main Methods:
- Literature review focusing on IBD-associated colorectal cancer.
- Analysis of molecular mechanisms involving cytokines, cyclooxygenase-2 (COX-2), and nuclear factor kappaB (NF-kappaB).
- Examination of experimental models of colitis-associated cancer.
Main Results:
- High levels of inflammatory mediators contribute to CRC development and progression in IBD.
- Cytokines released by epithelial and immune cells play a role in IBD-associated neoplasia.
- Key inflammatory genes (COX-2, NF-kappaB) and signaling pathways (TNF-alpha, IL-6) provide mechanistic links between inflammation and cancer.
Conclusions:
- Chronic inflammation in IBD is a significant driver of colorectal cancer development.
- Understanding the molecular pathways involved is crucial for developing targeted therapies.
- Further research into inflammation-cancer interplay can improve management of IBD patients at risk for CRC.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...